Recursion Pharmaceuticals, Inc. (RXRX) — Dilution Risk Analysis
Current Snapshot
Recursion Pharmaceuticals, Inc. (RXRX) has a DilutionWatch score of 37/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 37/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, SC 13G 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-10-02 | 0001601830-26-000115 |
| 4 | 2026-10-02 | 0001601830-26-000116 |
| 4 | 2026-09-16 | 0001601830-26-000110 |
| 4 | 2026-09-10 | 0001601830-26-000105 |
| 4 | 2026-09-02 | 0001601830-26-000103 |
| 4 | 2026-08-18 | 0001712276-26-000009 |
| 4 | 2026-08-18 | 0002006495-26-000012 |
| 4 | 2026-08-18 | 0002020969-26-000006 |
| SC 13G | 2026-08-07 | 0000093751-26-000530 |
| 4 | 2026-08-06 | 0001856094-26-000014 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $300,000,000 | Source |
| Cash runway | 16 months | Source |
| Three-year share count growth | 163.94% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 37/10) Source
- Cash Runway
- 16 months Source
- ATM Offering Capacity Remaining
- $300,000,000 Source
- Share Count Growth (3-Year)
- 163.94% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.